Last $36.34 USD
Change Today +0.99 / 2.80%
Volume 156.8K
ESPR On Other Exchanges
Symbol
Exchange
NASDAQ GM
Stuttgart
As of 8:10 PM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Roger S. Newton Ph.D., FAHA

Executive Chairman and Chief Scientific Officer, Esperion Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 64 board members in 7 different organizations across 9 different industries.

See Board Relationships
63$1,829,635
As of Fiscal Year 2013

Background*

Dr. Roger S. Newton, Ph.D., FAHA, co-founded Esperion Therapeutics, Inc. (Esperion) in July 1998 and has been its Executive Chairman and Chief Scientific Officer since January 4, 2013. Dr. Newton serves as Chief Executive Officer of Esperion II and an advisor to a VC firm. Dr. Newton serves as Senior Vice President of Pfizer (China) Research and Development Co. Ltd. (Pfizer Global R&D). He served as President and Chief Executive Officer of Esperion Therapeutics, Inc. ...

Read Full Background

Corporate Headquarters*

46701 Commerce Center Drive
Plymouth, Michigan 48170

United States

Phone: 734-862-4840
Fax: --

Board Members Memberships*

Director
Former Chief Executive Officer, President, Member of Advisory Board and Director
Director
Director
1998-Present
Executive Chairman and Chief Scientific Officer
2007-N/A
Former Member of Clinical Advisory Board
2007-Present
Director

Education*

BA
Lafayette College
PhD
University of California, Davis
MS
University of Connecticut

Other Affiliations*

Annual Compensation*

Salary$375,000
Total Annual Compensation$375,000

Stock Options*

Exercisable Options81,766
Unexercisable Options104,375
Total Number of Options186,141

Total Compensation*

Total Annual Cash Compensation$525,000
Total Short Term Compensation$375,000
Total Calculated Compensation$1,829,635
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ESPR:US $36.34 USD +0.99

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ESPERION THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.